title: Allogeneic stem cell transplantation in chronic lymphocytic leukemia: the con's.
authors.affiliation: Medizinische Klinik III, Klinikum, Universität München, Grosshadern, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Hallek
authors.forename: M
authors.initials: M
authors.lastname: Bergmann
authors.forename: C M
authors.initials: CM
authors.lastname: Wendtner
authors.forename: G
authors.initials: G
authors.lastname: Fingerle-Rowson
authors.forename: B
authors.initials: B
authors.lastname: Schmitt
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D033581:Stem Cell Transplantation; D015996:Survival Rate; D014184:Transplantation, Homologous
chemical_list: D000970:Antineoplastic Agents